CATRENE Programme to Succeed MEDEA+ as European Nanoelectronics R&D Champion

MEDEA+, the EUREKA pan-European Programme for advanced co-operative Research and Development in Microelectronics, today announced details of the new EUREKA programme called CATRENE (Cluster for Application and Technology Research in Europe on NanoElectronics) that will take up the challenge of increasing Europe's strength in micro- and nanoelectronics after the highly successful MEDEA+ programme reaches its conclusion in 2008. A public/private partnership aimed at ensuring the continued development of European expertise in semiconductor technology and applications, CATRENE will build on the success of MEDEA+ and the previous EUREKA programmes JESSI and MEDEA in fostering the continued development of a dynamic European ecosystem with the critical mass necessary to compete at a global level in high technology industries as these move into the era of nanoelectronics.

Since its inception in 2001, MEDEA+ has made significant contributions to establishing and maintaining European leadership in fields ranging from smart card and image sensing technologies to automotive electronics. European IC companies have successfully developed three basic CMOS process generations in a time schedule in line with or even ahead of the global ITRS roadmap. Three European semiconductor companies are ranked amongst the world wide top ten and Europe's semiconductor industry has 10% of the world wide market. European champions with a strong global market position as wafer processing equipment suppliers, lithography tool and infrastructure suppliers as well as substrate and material suppliers have been added to the industrial landscape.

Like MEDEA+, CATRENE embraces all key actors in the value chain - including applications, technology, materials and equipment suppliers - as well as involving industrial companies of all sizes, universities and other research institutions, supported by Public Authorities. In this way CATRENE will benefit from the strong infrastructure for cross-border cooperation that has been developed by MEDEA+ and its predecessors.

An important feature of CATRENE is the concept of Lighthouse Projects, which address major socioeconomic needs such as transportation, healthcare, security, energy and entertainment through focussed R&D programmes. In the foreseeable future, the role of electronics and information systems will further increase as European society is faced with structural problems such as ageing of the population, exploding healthcare cost, transportation bottlenecks, rising energy costs and the need to increase productivity to be competitive on a worldwide basis. These societal challenges are also major opportunities for European industry and are designed to help European companies to address these new lead markets and to become worldwide market leaders. The "umbrella" lighthouse projects will serve as a focus for specific technology and applications development projects that address these challenges.

"For more than a decade, the EUREKA JESSI, MEDEA and MEDEA+ programmes have made it possi-ble for Europe's industry to reinforce its position in semiconductor process technology, manufac-turing and applications, and to become a key supplier to markets such as telecommunications, consumer electronics and automotive electronics", said Jozef Cornu, Chairman of MEDEA+ and designated Chairman of CATRENE. "Nanoelectronics will offer enormous opportunities to those who are the first to master and bring to market new technologies and applications and we believe that CATRENE will play a vital role in helping Europe's microelectronics industry to go from strength to strength."

While the JESSI, MEDEA and MEDEA+ programmes were divided into technology and applications sub-programmes, CATRENE recognises the increasing convergence of technology and applications. It will therefore focus on large identified application markets, deriving from these the roadmap of required technologies. Key technology goals include maintaining and increasing Europe's strength in IP (Intellectual Property) across the entire electronics supply chain and its leadership in lithography and Silicon-on-Insulator materials; ensuring that European companies are among the world leaders in the advanced semiconductor technologies that allow entire systems to be integrated in a single package; and strengthening European expertise in applying a deep knowledge of semiconductor process technology to efficient design for new electronics applications.

For more information on MEDEA+ and CATRENE visit http://www.medeaplus.org.

About MEDEA+
The MEDEA+ programme (2001-2008) comprised 77 projects involving 20,000 person-years and around 450 partner organisations from large companies (38 %), SMEs (37%), institutes and academia (25%). It delivered important innovations in key application areas such as automotive and traffic control, broadband communications, secure society, energy saving and healthcare.

About CATRENE
CATRENE is a four-year programme, starting 1 January 2008 and extendable by another four years. This is in line with the changing landscape of the semiconductor industry as well as the present view on technology evolution and the time span over which most of the major applications will develop. Resources required will be annually around 4,000 person-years, equalling about € 6 billion for the extended programme.

Most Popular Now

DMEA 2025: Digital Health Worldwide in B…

8 - 10 April 2025, Berlin, Germany. From the AI Act, to the potential of the European Health Data Space, to the power of patient data in Scandinavia - DMEA 2025...

Is AI in Medicine Playing Fair?

As artificial intelligence (AI) rapidly integrates into health care, a new study by researchers at the Icahn School of Medicine at Mount Sinai reveals that all generative AI models may...

New System for the Early Detection of Au…

A team from the Human-Tech Institute-Universitat Politècnica de València has developed a new system for the early detection of Autism Spectrum Disorder (ASD) using virtual reality and artificial intelligence. The...

Generative AI's Diagnostic Capabili…

The use of generative AI for diagnostics has attracted attention in the medical field and many research papers have been published on this topic. However, because the evaluation criteria were...

Diagnoses and Treatment Recommendations …

A new study led by Prof. Dan Zeltzer, a digital health expert from the Berglas School of Economics at Tel Aviv University, compared the quality of diagnostic and treatment recommendations...

AI Tool can Track Effectiveness of Multi…

A new artificial intelligence (AI) tool that can help interpret and assess how well treatments are working for patients with multiple sclerosis (MS) has been developed by UCL researchers. AI uses...

Surrey and Sussex Healthcare NHS Trust g…

Surrey and Sussex Healthcare NHS Trust has marked an important milestone in connecting busy radiologists across large parts of South East England, following the successful go live of Sectra's enterprise...

Dr Jason Broch Joins the Highland Market…

The Highland Marketing advisory board has welcomed a new member - Dr Jason Broch, a GP and director with a strong track record in the NHS and IT-enabled transformation. Dr Broch...

AI-Driven Smart Devices to Transform Hea…

AI-powered, internet-connected medical devices have the potential to revolutionise healthcare by enabling early disease detection, real-time patient monitoring, and personalised treatments, a new study suggests. They are already saving lives...

Multi-Resistance in Bacteria Predicted b…

An AI model trained on large amounts of genetic data can predict whether bacteria will become antibiotic-resistant. The new study shows that antibiotic resistance is more easily transmitted between genetically...

DMEA 2025 Ends with Record Attendance an…

8 - 10 April 2025, Berlin, Germany. DMEA 2025 came to a successful close with record attendance and an impressive program. 20,500 participants attended Europe's leading digital health event over the...

A Novel AI-Based Method Reveals How Cell…

Researchers from Tel Aviv University have developed an innovative method that can help to understand better how cells behave in changing biological environments, such as those found within a cancerous...